Highlighted Text:
Show |
Hide
Full text loading...
Chapter 7 : Protozoa and Helminths
Author:
Barbara L. Herwaldt
Content Type: Reference
Publication Year:
2006
Category: Clinical Microbiology; Applied and Industrial Microbiology
Book DOI:
10.1128/9781555815899
Chapter DOI:
10.1128/9781555815899.ch7
MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.
Preview this chapter:
Protozoa and Helminths, Page 1 of 2
< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555815899/9781555813390_Chap07-1.gif /docserver/preview/fulltext/10.1128/9781555815899/9781555813390_Chap07-2.gif
Abstract:
This chapter educates laboratorians, biosafety personnel, and health care workers about the potential hazards of working in settings in which exposures to viable parasites could occur. It provides information about parasites that have caused or could cause accidental infections in laboratorians and health care workers. Factors that influence whether infection and disease develop after accidental exposures are also provided in this chapter. The chapter focuses on the protozoa that cause leishmaniasis, malaria, toxoplasmosis, Chagas’ disease (American trypanosomiasis), and African trypanosomiasis. Summary data about 180 occupationally acquired cases of infection with the protozoa that cause these diseases are provided in this chapter. Blood and tissue protozoa of potential relevance to laboratorians and health care workers are also discussed in this chapter. Few laboratory-acquired helminthic infections have been reported. Even if laboratorians became infected by ingestion of infective eggs or through penetration of skin by infective larvae, they typically would have low worm burdens and few, if any, symptoms because most helminths do not multiply in humans. The fact that some of the persons who acquired parasitic infections did not recall discrete exposures suggests that subtle exposures (e.g., contamination of unrecognized microabrasions and exposure through aerosolization or droplet spread) can result in infection.
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
Key Concept Ranking
- Clinical and Public Health
- 0.79956347
- Parasitic Diseases
- 0.51421344
- Trypanosoma brucei gambiense
- 0.49081084
- Trypanosoma brucei rhodesiense
- 0.48843405
0.79956347
Figures
Protozoa and Helminths
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815899.ch07-1,webId=/content/author/10.1128/9781555815899.ch07-1,properties={foaf_givenname=Barbara L., foaf_name=Barbara L. Herwaldt, foaf_surname=Herwaldt}]]
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07fig01
FIGURE 1
Incubation period (i.e., period from accidental exposure until first symptom or clinical manifestation attributed to infection) for the clinically evident occupationally acquired cases of infection with various blood and tissue protozoa. The ends of the lines designate the extremes of the ranges, and the short vertical lines designate the medians. For malaria, only non-vector-borne cases with available data were included (n = 20 caused by P. falciparum and n = 3 caused by P. vivax). For toxoplasmosis, only cases related to exposure to tissue stages of the parasite (rather than oocysts) were included. See text for discussion of general factors that affect incubation periods (e.g., virulence of parasite and accurate recall of timing of relevant exposure and first clinical manifestations) and specific issues about the data for the various parasites.
10.1128/9781555815899/f0126-01_thmb.gif
10.1128/9781555815899/f0126-01.gif
FIGURE 1
Incubation period (i.e., period from accidental exposure until first symptom or clinical manifestation attributed to infection) for the clinically evident occupationally acquired cases of infection with various blood and tissue protozoa. The ends of the lines designate the extremes of the ranges, and the short vertical lines designate the medians. For malaria, only non-vector-borne cases with available data were included (n = 20 caused by P. falciparum and n = 3 caused by P. vivax). For toxoplasmosis, only cases related to exposure to tissue stages of the parasite (rather than oocysts) were included. See text for discussion of general factors that affect incubation periods (e.g., virulence of parasite and accurate recall of timing of relevant exposure and first clinical manifestations) and specific issues about the data for the various parasites.
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
References
/content/book/10.1128/9781555815899.ch07
1.
Abramowicz, M. (ed.). 2004. Drugs for parasitic infections. Med. Lett. Drugs Ther. August: 1–12. [Online.] http://www.medletter.com/freedocs/parasitic.pdf.
2.
Abulrahi, H. A.,, E. A. Bohlega,, R. E. Fontaine,, S. M. alSeghayer, and, A. A. al-Ruwais. 1997. Plasmodium falciparum malaria transmitted in hospital through heparin locks. Lancet 349: 23– 25.
3.
Allain, D. S., and, I. G. Kagan. 1974. Isolation of Trypanosoma cruzi in an acutely infected patient. J. Parasitol. 60: 526– 527.
4.
Al-Saigul, A. M.,, R. E. Fontaine, and, Q. Haddad. 2000. Nosocomial malaria from contamination of a multidose heparin container with blood. Infect. Control Hosp. Epidemiol. 21: 329– 330.
5.
Alweis, R. L.,, K. DiRosario,, G. Conidi,, K. C. Kain,, R. Olans, and, J. L. Tully. 2004. Serial nosocomial transmission of Plasmodium falciparum malaria from patient to nurse to patient. Infect. Control Hosp. Epidemiol. 25: 55– 59.
6.
Anderson, B. C. 1985. Moist heat inactivation of Cryptosporidium sp. Am. J. Public Health 75: 1433– 1434.
7.
Anderson, B. C.,, T. Donndelinger,, R. M. Wilkins, and, J. Smith. 1982. Cryptosporidiosis in a veterinary student. J. Am. Vet. Med. Assoc. 180: 408– 409.
8.
Añez, N.,, H. Carrasco,, H. Parada,, G. Crisante,, A. Rojas,, N. Gonzalez,, J. L. Ramirez,, P. Guevara,, C. Rivero,, R. Borges, and, J. V. Scorza. 1999. Acute Chagas’ disease in western Venezuela: a clinical, seroparasitologic, and epidemiologic study. Am. J. Trop. Med. Hyg. 60: 215– 222.
9.
Antunes, F.,, M. Forte,, L. Tavares,, J. Botas,, C. Carvalho,, H. Carmona, and, F. C. Araujo. 1987. Malaria in Portugal 1977–1986. Trans. R. Soc. Trop. Med. Hyg. 81: 561– 562.
10.
Araujo, F. M. G.,, M. T. Bahia,, N. M. Magalhaes,, O. A. Martins-Filho,, V. M. Veloso,, C. M. Carneiro,, W. L. Tafuri, and, M. Lana. 2002. Follow-up of experimental chronic Chagas’ disease in dogs: use of polymerase chain reaction (PCR) compared with parasitological and serological methods. Acta Trop. 81: 21– 31.
11.
Arikan, S.,, S. Ergüven,, Y. Aryön, and, A. Günalp. 1999. Cryptosporidiosis in immunocompromised patients in a Turkish university hospital. Acta Microbiol. Immunol. Hung. 46: 33– 40.
12.
Arness, M. K.,, J. D. Brown,, J. P. Dubey,, R. C. Neafie, and, D. E. Granstrom. 1999. An outbreak of acute eosinophilic myositis attributed to human Sarcocystis parasitism. Am. J. Trop. Med. Hyg. 61: 548– 553.
13.
Aronson, P. R. 1962. Septicemia from concomitant infection with Trypanosoma cruzi and Neisseria perflava. First case of laboratory-acquired Chagas’ disease in the United States. Ann. Intern. Med. 57: 994– 1000.
14.
Ashton, C. R., and, O. D. Beresford. 1974. Fascioliasis. Br. Med. J. 2: 121. (Letter.)
15.
Baker, C. C.,, C. P. Farthing, and, P. Ratnesar. 1984. Toxoplasmosis, an innocuous disease? J. Infect. 8: 67– 69.
16.
Baxby, D.,, C. A. Hart, and, C. Taylor. 1983. Human cryptosporidiosis: a possible case of hospital cross infection. Br. Med. J. 287: 1760– 1761.
17.
Beaver, P. C.,, R. K. Gadgil, and, P. Morera. 1979. Sarcocystis in man: a review and report of five cases. Am. J. Trop. Med. Hyg. 28: 819– 844.
18.
Bending, M. R., and, P. D. L. Maurice. 1980. Malaria: a laboratory risk. Postgrad. Med. J. 56: 344– 345. (Case reports.)
19.
Beresford, O. D. 1976. A case of fascioliasis in man. Vet. Rec. 98: 15.
20.
Berman, J. D. 1997. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin. Infect. Dis. 24: 684– 703.
21.
Beverley, J. K. A.,, E. Skipper, and, S. C. Marshall. 1955. Acquired toxoplasmosis: with a report of a case of laboratory infection. Br. Med. J. 1: 577– 578.
22.
Blagburn, B. L., and, W. L. Current. 1983. Accidental infection of a researcher with human Cryptosporidium. J. Infect. Dis. 148: 772– 773.
23.
Blewett, D. A. 1988. Disinfection and oocysts, p. 107–115. In K. W. Angus and, D. A. Blewett (ed.), Proceedings of the 1st International Workshop on Cryptosporidiosis. Moredun Research Institute, Edinburgh, Scotland.
24.
Börsch, G.,, J. Odendahl,, G. Sabin, and, D. Ricken. 1982. Malaria transmission from patient to nurse Lancet ii: 1212. (Letter.)
25.
Bouree, P., and, E. Fouquet. 1978. Paludisme: contamination directe interhumaine. Nouv. Presse Med. 7: 1865. (Letter.)
26.
Bouteille, B.,, M. L. Darde,, P. Weinbreck, J. C. Voultoury,, R. Gobeaux, and, M. Pestre-Alexandre. 1990. Pernicious malaria by accidental needle inoculation. Bull. Soc. Fr. Parasitol. 8: 69– 72. (In French.)
27.
Brener, Z. 1984. Laboratory-acquired Chagas’ disease: an endemic disease among parasitologists? p. 3–9. In C. M. Morel (ed.), Genes and Antigens of Parasites: a Laboratory Manual, 2nd ed. Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
28.
Brener, Z. 1987. Laboratory-acquired Chagas disease: comment. Trans. R. Soc. Trop. Med. Hyg. 81: 527. (Letter.)
29.
Brown, J., and, L. Jacobs. 1956. Adult toxoplasmosis: report of a case due to laboratory infection. Ann. Intern. Med. 44: 565– 572.
30.
Bruce-Chwatt, L. J. 1972. Blood transfusion and tropical disease. Trop. Dis. Bull. 69: 825– 862.
31.
Bruce-Chwatt, L. J. 1982. Imported malaria: an uninvited guest. Br. Med. Bull. 38: 179– 185.
32.
Burne, J. C. 1970. Malaria by accidental inoculation. Lancet ii: 936. (Letter.)
33.
Campbell, I.,, S. Tzipori,, G. Hutchison, and, K. W. Angus. 1982. Effect of disinfectants on survival of Cryptosporidium oocysts. Vet. Rec. 111: 414– 415.
34.
Cannon, N. J., S. P. Walker, and, W. E. Dismukes. 1972. Malaria acquired by accidental needle puncture. JAMA 222:1425. (Letter.)
35.
Carosi, G.,, A. Maccabruni,, F. Castelli, and, P. Viale. 1986. Accidental and transfusion malaria in Italy. Trans. R. Soc. Trop. Med Hyg. 80: 667– 668. (Letter.)
36.
Carrière, J.,, A. Datry,, I. Hilmarsdottir,, M. Danis, and, M. Gentilini. 1993. Transmission of Plasmodium falciparum following an accidental sting. Presse Med. 22: 1707. (In French.)
37.
Casemore, D. P.,, C. A. Gardner, and, C. O’Mahony. 1994. Cryptosporidial infection, with special reference to nosocomial transmission of Cryptosporidium parvum: a review. Folia Parasitol. 41: 17– 21.
38.
CDSC. 1997. Needlestick malaria with tragic consequences. Commun. Dis. Rep. Wkly. 7: 247.
39.
CDSC. 1999. Hospital-acquired malaria in Nottingham. Commun. Dis. Rep. Wkly. 9: 123.
40.
Center for Disease Control. 1972. Malaria Surveillance 1971 Annual Report. DHEW publication (HSM) 72–8152. Center for Disease Control, Atlanta, Ga.
41.
Centers for Disease Control. 1980. Chagas’ disease— Michigan. Morb. Mortal. Wkly. Rep. 29: 147– 148.
42.
Centers for Disease Control. 1984. Malaria Surveillance Annual Summary 1982. Centers for Disease Control, Atlanta, Ga.
43.
Centers for Disease Control and Prevention. 2001a. Malaria surveillance—United States, 1996. Morb. Mortal. Wkly. Rep. 50 (SS-1) : 1– 52.
44.
Centers for Disease Control and Prevention. 2001b. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. Morb. Mortal. Wkly. Rep. 50 (RR-11) : 1– 52. [Online.] http://www.cdc.gov/mmwr/PDF/rr/rr5011.pdf.
45.
Centers for Disease Control and Prevention. 2002. Malaria surveillance—United States, 2000. Morb. Mortal. Wkly. Rep. 51 (SS-5) : 9– 21.
46.
Centers for Disease Control and Prevention and National Institutes of Health. 2006. Biosafety in Microbiological and Biomedical Laboratories, 5th ed. L. C. Chosewood and D. E. Wilson (ed.). U.S. Department of Health and Human Services, Washington, D.C.
47.
Chen, K.-T., C.-J. Chen, P.-Y. Chang, and, D. L. Morse. 1999. A nosocomial outbreak of malaria associated with contaminated catheters and contrast medium of a computed tomographic scanner. Infect. Control Hosp. Epidemiol. 20: 22– 25.
48.
Chung, H.-L. 1931. An early case of kala-azar, possibly an oral infection in the laboratory. Natl. Med. J. China 17: 617– 621.
49.
Clinical and Laboratory Standards Institute. 2005. Protection of Laboratory Workers from Occupationally Acquired Infections: Approved Guideline, 3rd ed. CLSA M29-A3. Clinical and Laboratory Standards Institute, Wayne, Pa.
50.
Coatney, G. R.,, W. E. Collins,, M. Warren, and, P. G. Contacos. 1971. The Primate Malarias. U.S. Government Printing Office, Washington, D.C.
51.
Coles, G. C. 1975. Gastro-intestinal allergy to nematodes. Trans. R. Soc. Trop. Med. Hyg. 69: 362– 363.
52.
Coles, G. C. 1985. Allergy and immunopathology of ascariasis, p. 167–184. In D. W. T. Crompton,, M. C. Nesheim, and, Z. S. Pawlowski (ed.), Ascariasis and Its Public Health Significance. Taylor and Francis, London, United Kingdom.
53.
Collins, W. E. 1982. Simian malaria, p. 141–150. In J. H. Steele,, L. Jacobs, and, P. Arambulo (ed.), Parasitic Zoonoses, vol. 1. CRC Press, Inc., Boca Raton, Fla.
54.
Contacos, P. G., and, W. E. Collins. 1973. Malarial relapse mechanism. Trans. R. Soc. Trop. Med. Hyg. 67: 617– 618.
55.
Cook, E. B. M. 1961. Safety in the public health laboratory. Public Health Rep. 76: 51– 56.
56.
Coudert, J.,, J. Despeignes,, M. R. Battesti, and, J. Michel-Brun. 1964. Un cas de maladie de Chagas par contamination accidentelle de laboratoire avec T. cruzi. Bull. Soc. Pathol. Exot. 57: 208– 213.
57.
Cross, J. H., M.-Y. Hsu-Kuo, and, J. C. Lien. 1973. Accidental human infection with Plasmodium cynomolgi bastianellii. Southeast Asian J. Trop. Med. Public Health 4: 481– 483.
58.
Current, W. L.,, N. C. Reese,, J. V. Ernst,, W. S. Bailey,, M. B. Heyman, and, W. M. Weinstein. 1983. Human cryptosporidiosis in immunocompetent and immunodeficient persons: studies of an outbreak and experimental transmission. N. Engl. J. Med. 308: 1252– 1257.
59.
Daumal, M.,, V. Verreman,, F. Daumal,, B. Manoury, and, E. Colpart. 1996. Plasmodium falciparum malaria acquired by accidental needle puncture. Med. Mal. Infect. 26: 797– 798. (Letter.) (In French.)
60.
Delgado, O.,, P. Guevara,, S. Silva,, E. Belfort, and, J. L. Ramirez. 1996. Follow-up of a human accidental infection by Leishmania (Viannia) braziliensis using conventional immunologic techniques and polymerase chain reaction. Am. J. Trop. Med. Hyg. 55: 267– 272.
61.
de Oliveira, C. G., and, F. Freire, Jr. 1948. An epidemic of inoculated malaria. Bol. Clin. Hosp. Civis Lisb. 12: 375– 404. (In Spanish.)
62.
de Titto, E. H., and, F. G. Araujo. 1988. Serum neuraminidase activity and hematological alterations in acute human Chagas’ disease. Clin. Immunol. Immunopathol. 46: 157– 161.
63.
Dillon, N. L.,, H. O. Stolf,, E. L. A. Yoshida, and, M. E. A. Marques. 1993. Leishmaniose cutânea acidental. Rev. Inst. Med. Trop. Sâo Paulo 35: 385– 387.
64.
Dobroszycki, J.,, B. L. Herwaldt,, F. Boctor,, J. R. Miller,, J. Linden,, M. L. Eberhard,, J. J. Yoon,, N. M. Ali,, H. B. Tanowitz,, F. Graham,, L. M. Weiss, and, M. Wittner. 1999. A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor. JAMA 281: 927– 930.
65.
Druilhe, P.,, J. F. Trape,, J. P. Leroy,, C. Godard, and, M. Gentilini. 1980. Two accidental human infections by Plasmodium cynomolgi bastianellii: a clinical and serological study. Ann. Soc. Belge Med. Trop. 60: 349– 354. (In French.)
66.
Dryjanski, J.,, J. W. M. Gold,, M. T. Ritchie,, R. C. Kurtz,, S. L. Lim, and, D. Armstrong. 1986. Cryptosporidiosis: case report in a health team worker. Am. J. Med. 80: 751– 752.
67.
Dubey, J. P., and, C. P. Beattie. 1988. Toxoplasmosis of Animals and Man. CRC Press, Inc., Boca Raton, Fla.
68.
Dubey, J. P., and, D. S. Lindsay. 1998. Isolation in immuno-deficient mice of Sarcocystis neurona from opossum ( Didelphis virginiana) faeces, and its differentiation from Sarcocystis falcatula. Int. J. Parasitol. 28: 1823– 1828.
69.
Dubey, J. P.,, C. A. Speer, and, R. Fayer. 1989. Sarcocystosis of Animals and Man. CRC Press, Inc., Boca Raton, Fla.
70.
Dziubek, Z.,, P. Kajfasz, and, W. Basiak. 1993. Hospital infection of tropical malaria in Poland. Wiad. Lek. 46: 860– 863. (In Polish.)
71.
Eberhard, M. L., N. J. Pieniazek, and, M. J. Arrowood. 1997. Laboratory diagnosis of Cyclospora infections. Arch. Pathol. Lab. Med. 121: 792– 797.
72.
Elsevier. 1998a. Schistosomiasis: symptoms of mild infections? Parasitol. Today 14: 8.
73.
Elsevier. 1998b. Accidental infections. Parasitol. Today 14: 55.
74.
Emeribe, A. O. 1988. Gambiense trypanosomiasis acquired from needle scratch. Lancet i: 470– 471. (Letter.)
75.
Evans, T. G., and, R. D. Pearson. 1988. Clinical and immunological responses following accidental inoculation of Leishmania donovani. Trans. R. Soc. Trop. Med. Hyg. 82: 854– 856.
76.
Eyles, D. E.,, G. R. Coatney, and, M. E. Getz. 1960. Vivax-type malaria parasite of macaques transmissible to man. Science 131: 1812– 1813.
77.
Field, P. R.,, G. G. Moyle, and, P. M. Parnell. 1972. The accidental infection of a laboratory worker with Toxoplasma gondii. Med. J. Aust. 2: 196– 198.
78.
Filho, A. A. F.,, A. O. Luquetti,, A. Prata,, A. Rassi,, E. D. Gontijo,, H. D. Ferreira,, J. R. Cancado,, J. R. Coura,, S. G. Andrade,, V. Macedo,, V. A. Neto,, W. de Oliveira, Jr., and, Z. Brener. 1997. Etiological treatment for Chagas disease. Parasitol. Today 13: 127– 128.
79.
Foot, A. B. M.,, A. Oakhill, and, M. G. Mott. 1990. Cryptosporidiosis and acute leukaemia. Arch. Dis. Child. 65: 236– 237.
80.
Freedman, A. M. 1987. Unusual forms of malaria transmission: a report of 2 cases. S. Afr. Med. J. 71: 183– 184.
81.
Freedman, D. O.,, J. D. MacLean, and, J. B. Viloria. 1987. A case of laboratory acquired Leishmania donovani infection: evidence for primary lymphatic dissemination. Trans. R. Soc. Trop. Med. Hyg. 81: 118– 119.
82.
Frenkel, J. K.,, R. W. Weber,, and M. N. Lunde. 1960. Acute toxoplasmosis: effective treatment with pyrimethamine, sulfadiazine, leucovorin calcium, and yeast. JAMA 173: 1471– 1476.
83.
Garcia, L. S. 2001. Diagnostic Medical Parasitology, 4th ed. ASM Press, Washington, D.C.
84.
Gardner, C. 1994. An outbreak of hospital-acquired cryptosporidiosis. Br. J. Nurs. 3: 152, 154– 158.
85.
Garnham, P. C. C. 1967. Malaria in mammals excluding man. Adv. Parasitol. 5: 139– 204.
86.
Giroud, P.,, P. Le Gac,, F. Roger, and, J.-A. Gaillard. 1953. La toxoplasmose de l’adulte. Sem. Hop. Paris 29: 4036– 4039.
87.
Gutteridge, W. E., B. Cover, and, A. J. D. Cooke. 1974. Safety precautions for work with Trypanosoma cruzi. Trans. R. Soc. Trop. Med. Hyg 68: 161.
88.
Hanson, W. L.,, R. F. Devlin, and, E. L. Roberson. 1974. Immunoglobulin levels in a laboratory-acquired case of human Chagas’ disease. J. Parasitol. 60: 532– 533.
89.
Haworth, F. L. M., and, G. C. Cook. 1995. Needlestick malaria. Lancet 346: 1361. (Letter.)
90.
Henderson, H. E.,, G. W. Gillepsie,, P. Kaplan, and, M. Steber. 1963. The human Isospora. Am. J. Hyg. 78: 302– 309.
91.
Herbert, W. J.,, D. Parratt,, N. Van Meirvenne, and, B. Lennox. 1980. An accidental laboratory infection with trypanosomes of a defined stock. II. Studies on the serological response of the patient and the identity of the infecting organism. J. Infect. 2: 113– 124.
92.
Hermentin, K.,, A. Hassl,, O. Picher, and, H. Aspöck. 1989. Comparison of different serotests for specific Toxoplasma IgM-antibodies (ISAGA, SPIHA, IFAT) and detection of circulating antigen in two cases of laboratory acquired Toxoplasma infection. Zentbl. Bakteriol. Mikrobiol. Hyg. A 270: 534– 541.
93.
Hermentin, K.,, O. Picher,, H. Aspöck,, H. Auer, and, A. Hassl. 1983. A solid-phase indirect haemadsorption assay (SPIHA) for detection of immunoglobulin M antibodies to Toxoplasma gondii: application to diagnosis of acute acquired toxoplasmosis. Zentbl. Bakteriol. Hyg. Mikrobiol. 1 Abt. Orig. A 255: 380– 391.
94.
Herr, A., and, L. Brumpt. 1939. Un cas aigu de maladie de Chagas contractée accidentellement au contact de triatomes Mexicains: observation et courbe fébrile. Bull. Soc. Pathol. Exot. 32: 565– 571.
95.
Herwaldt, B. L. 1999a. Leishmaniasis. Lancet 354: 1191– 1199.
96.
Herwaldt, B. L. 1999b. Miltefosine: the long-awaited therapy for visceral leishmaniasis? N. Engl. J. Med. 341: 1840– 1842.
97.
Herwaldt, B. L. 2000a. Protozoa and helminths, p. 89–110. In D. O. Fleming and, D. L. Hunt (ed.), Biological Safety: Principles and Practices, 3rd ed. ASM Press, Washington, D.C.
98.
Herwaldt, B. L. 2000b. Cyclospora cayetanensis : a review, focusing on the outbreaks of cyclosporiasis in the 1990s. Clin. Infect. Dis. 31: 1040– 1057.
99.
Herwaldt, B. L. 2001. Laboratory-acquired parasitic infections from accidental exposures. Clin. Microbiol. Rev. 14: 659– 688.
100.
Herwaldt, B. L., and, J. D. Berman. 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am. J. Trop. Med. Hyg. 46: 296– 306.
101.
Herwaldt, B. L.,, S. Cacciò, F. Gherlinzoni,, H. Aspöck,, S. B. Slemenda,, P. Piccaluga,, G. Martinelli,, R. Edelhofer,, U. Hollenstein,, G. Poletti,, S. Pampiglione,, K. Löschenberger,, S. Tura, and, N. J. Pieniazek. 2003. Molecular characterization of a non- Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg. Infect. Dis. 9: 942– 948.
102.
Herwaldt, B. L.,, G. de Bruyn,, N. J. Pieniazek,, M. Homer,, K. H. Lofy,, S. B. Slemenda,, T. R. Fritsche,, D. H. Persing, and, A. P. Limaye. 2004. Babesia divergens-like infection, Washington State. Emerg. Infect. Dis. 10: 622– 629.
103.
Herwaldt, B. L., and, D. D. Juranek. 1993. Laboratory-acquired malaria, leishmaniasis, trypanosomiasis, and toxoplasmosis. Am. J. Trop. Med. Hyg. 48: 313– 323.
104.
Herwaldt, B. L., and, D. D. Juranek. 1995. Protozoa and helminths, p. 77–91. In D. O. Fleming,, J. H. Richardson,, J. I. Tulis, and, D. Vesley (ed.), Laboratory Safety: Principles and Practices, 2nd ed. ASM Press, Washington, D.C.
105.
Hira, P. R.,, R. Siboo,, S. Al-Kandari, and, K. Behbehani. 1987. Induced malaria and antibody titres in acute infections and in blood donors in Kuwait. Trans. R. Soc. Trop. Med. Hyg. 81: 391– 394.
106.
Hofflin, J. M.,, R. H. Sadler,, F. G. Araujo,, W. E. Page, and, J. S. Remington. 1987. Laboratory-acquired Chagas disease. Trans. R. Soc. Trop. Med. Hyg. 81: 437– 440.
107.
Hojlyng, N.,, W. Holten-Andersen, and, S. Jepsen. 1987. Cryptosporidiosis: a case of airborne transmission. Lancet ii: 271– 272. (Letter.)
108.
Holm, K. 1924. Subtertian malaria acquired from a corpse. Klin. Wochenschr. 3: 1633– 1634. (In German.)
109.
Hörmann, J. 1955. Laborinfekt mit Toxoplasma gondii (Beitrag zum klinischen Bild der akuten Erwachsenentoxoplasmose). Z. Gesamte Inn. Med. Grenzgeb. 18: 150– 152.
110.
Hudson, L.,, F. Grover,, W. E. Gutteridge,, R. A. Klein,, W. Peters,, R. A. Neal,, M. A. Miles,, J. E. Williams,, M. T. Scott,, R. Nourish, and, B. P. Ager. 1983. Suggested guidelines for work with live Trypanosoma cruzi. Trans. R. Soc. Trop. Med. Hyg. 77: 416– 419.
111.
Jacobs, L. 1957. The interrelation of toxoplasmosis in swine, cattle, dogs, and man. Public Health Rep. 72: 872– 882.
112.
Jain, S. K.,, D. Persaud,, T. M. Perl,, M. A. Pass,, K. M. Murphy,, J. M. Pisciotta,, P. F. Scholl,, J. F. Casella, and, D. J. Sullivan. 2005. Nosocomial malaria and saline flush. Emerg. Infect. Dis. 11: 1097– 1099.
113.
Jeffery, G. M. 1956. Human coccidiosis in South Carolina. J. Parasitol. 42: 491– 495.
114.
Jensen, J. B.,, T. C. Capps, and, J. M. Carlin. 1981. Clinical drug-resistant falciparum malaria acquired from cultured parasites. Am. J. Trop. Med. Hyg. 30: 523– 525.
115.
Jones, J. 2000. Recommendations from an external review following transmission of malaria in hospital. Eurosurveillance Wkly. 4 (10). [Online.] http://www.eurosurveillance.org/ew/2000/000309.asp#3.
116.
Kayhoe, D. E.,, L. Jacobs,, H. K. Beye, and, N. B. McCullough. 1957. Acquired toxoplasmosis: observations on two parasitologically proved cases treated with pyrimethamine and triple sulfonamides. N. Engl.J. Med. 257: 1247– 1254.
117.
Kirchgatter, K.,, G. Wunderlich,, M. S. Branquinho,, T. M. Salles,, Y. C. Lian,, R. A. Carneiro-Junior, and, S. M. Di Santi. 2002. Molecular typing of Plasmodium falciparum from Giemsa-stained blood smears confirms nosocomial malaria transmission. Acta Trop. 84: 199– 203.
118.
Kirchhoff, L. V., and, J. E. Donelson. E. Donelson. PCR detection of Trypanosoma cruzi, African trypanosomes, and Leishmania species, p. 443–455. In D. H. Persing,, F. C. Tenover,, T. F. Smith, and, T. J. White (ed.), Diagnostic Molecular Microbiology—Principles and Applications. American Society for Microbiology, Washington, D.C.
119.
Kirchhoff, L. V., and, D. F. Hoft. 1990. Immunization and challenge of mice with insect-derived metacyclic trypomastigotes of Trypanosoma cruzi. Parasite Immunol. 12: 65– 74.
120.
Kirchhoff, L. V.,, J. R. Votava,, D. E. Ochs, and, D. R. Moser. 1996. Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi. J. Clin. Microbiol. 34: 1171– 1175.
121.
Knobloch, J., and, M. Demar. 1997. Accidental Leishmania mexicana infection in an immunosuppressed laboratory technician. Trop. Med. Int. Health 2: 1152– 1155.
122.
Koch, K. L.,, D. J. Phillips,, R. C. Aber, and, W. L. Current. 1985. Cryptosporidiosis in hospital personnel: evidence for person-to-person transmission. Ann. Intern. Med. 102: 593– 596.
123.
Kociecka, W., and, B. Skoryna. 1987. Falciparum malaria probably acquired from infected skin-cut. Lancet ii: 220. (Letter.)
124.
Konkle, D. M.,, K. M. Nelson, and, D. P. Lunn. 1997. Nosocomial transmission of Cryptosporidium in a veterinary hospital. J. Vet. Intern. Med. 11: 340– 343.
125.
Krause, P. J.,, T. Lepore, V. K. Sikand,, J. Gadbaw,, G. Burke,, S. R. Telford,, P. Brassard,, D. Pearl,, J. Azlanzadeh,, D. Christianson,, D. McGrath, and, A. Spielman. 2000. Atovaquone and azithromycin for the treatment of babesiosis. N. Engl. J. Med. 343: 1454– 1458.
126.
Lengerich, E. J.,, D. G. Addiss,, J. J. Marx,, B. L. P. Ungar, and, D. D. Juranek. 1993. Increased exposure to cryptosporidia among dairy farmers in Wisconsin. J. Infect. Dis. 167: 1252– 1255.
127.
Lettau, L. A. 1991a. Nosocomial transmission and infection control aspects of parasitic and ectoparasitic diseases. I. Introduction/enteric parasites. Infect. Control Hosp. Epidemiol. 12: 59– 65.
128.
Lettau, L. A. 1991b. Nosocomial transmission and infection control aspects of parasitic and ectoparasitic diseases. II. Blood and tissue parasites. Infect. Control Hosp. Epidemiol. 12: 111– 121.
129.
Levine, J. F.,, M. G. Levy,, R. L. Walker, and, S. Crittenden. 1988. Cryptosporidiosis in veterinary students. J. Am. Vet. Med. Assoc. 193: 1413– 1414.
130.
Lewis, J. 1971. Iatrogenic malaria. N. Z. Med. J. 71: 88– 89.
131.
Lloyd Jones, T., and, A. A. Kingscote. 1935. Observations on Ascaris sensitivity in man. Am. J. Hyg. 22: 406– 413.
132.
Lumsden, W. H. R.,, C. D. Kimber,, D. A. Evans, and, S. J. Doig. 1979. Trypanosoma brucei : miniature anion-exchange centrifugation technique for detection of low parasitemias: adaptation for field use. Trans. R. Soc. Trop. Med. Hyg. 73: 312– 317.
133.
Magnus, E.,, T. Vervoort, and, N. van Meirvenne. 1978. A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. b. gambiense trypanosomiasis. Ann. Soc. Belge Med. Trop. 58: 169– 176.
134.
Maligin, S. A. 1958. A case of cutaneous form of strongyloidiasis caused by larvae of S. ransomi, S. westeri and S. papillosus. Med. Parazitol. 27: 446– 447.
135.
Mandell, G. L.,, J. E. Bennett, and, R. Dolin (ed.). 2005. Principles and Practice of Infectious Diseases, 6th ed. Churchill Livingstone, Inc., Philadelphia, Pa.
136.
Marsh, A. E.,, B. C. Barr,, J. Lakritz,, R. Nordhausen,, J. E. Madigan, and, P. A. Conrad. 1997. Experimental infection of nude mice as a model for Sarcocystis neurona- associated encephalitis. Parasitol. Res. 83: 706– 711.
137.
Martinez, A. J., and, G. S. Visvesvara. 1997. Free-living, amphizoic and opportunistic amebas. Brain Pathol. 7: 583– 598.
138.
Martino, P.,, G. Gentile,, A. Caprioli,, L. Baldassarri,, G. Donelli,, W. Arcese,, S. Fenu,, A. Micozzi,, M. Venditti, and, F. Mandelli. 1988. Hospital-acquired cryptosporidiosis in a bone marrow transplantation unit. J. Infect. Dis. 158: 647– 648.
139.
McCracken, A. W. 1972. Natural and laboratory-acquired infection by Isospora belli. South. Med. J. 65: 800, 818.
140.
Melzer, H., and, W. Kollert. 1963. Ein Beitrag zur Klinik und Therapie der Chagas-Krankheit. Dtsch. Med. Wochenschr. 88: 368– 377.
141.
Miller, N. L.,, J. K. Frenkel,, and J. P. Dubey. 1972. Oral infections with Toxoplasma cysts and oocysts in felines, other mammals, and in birds. J. Parasitol. 58: 928– 937.
142.
Moretti, E.,, B. Basso,, I. Castro, M. C. Paez,, M. Chaul,, G. Barbieri,, D. C. Feijoo,, M. J. Sartori, and, R. C. Paez. 2005. Chagas’ disease: study of congenital transmission in cases of acute maternal infection. Rev. Soc. Bras. Med. Trop. 38: 53– 55.
143.
Moro, M. L.,, R. Romi,, C. Severini,, G. P. Casadio,, G. Sarta,, G. Tampieri,, A. Scardovi,, C. Pozzetti, and the Malaria Outbreak Group. 2002. Patient-to-patient transmission of noscomial malaria in Italy. Infect. Control Hosp. Epidemiol. 23: 338– 341.
144.
Mortimer, P. P. 1997. Nosocomial malaria. Lancet 349: 574. (Letter.)
145.
Most, H. 1973. Plasmodium cynomolgi malaria: accidental human infection. Am. J. Trop. Med. Hyg. 22: 157– 158.
146.
Müller, W. A.,, D. Wachtel, and, I. Färber. 1972. Beziehungen zwischen indirekter Immunfluoreszenzreaktion, Serofarbtest und Komplementbindungsreaktion auf Toxoplasmose mit Titerverlaufsuntersuchungen bei zwei Laborinfektionen. Dtsch. Gesundheitswesen. 27: 82– 85.
147.
Napoli, V. M., and, J. E. McGowan. 1987. How much blood is in a needlestick? J. Infect. Dis. 155: 828. (Letter.)
148.
Navarrete, S., H. C. Stetler,, C. Avila,, J. A. G. Aranda, and, J. I. Santos-Preciado. 1991. An outbreak of Cryptosporidium diarrhea in a pediatric hospital. Pediatr. Infect. Dis. J. 10: 248– 250.
149.
Navarro, P.,, A. Betancurt,, H. Paublini,, I. Medina,, M. J. Núñez, and, M. Domínguez. 1987. Falciparum malaria as a hospital-acquired infection. Bol. Sanit. Panam. 102: 476– 482. (In Spanish.)
150.
Neill, M. A.,, S. K. Rice,, N. V. Ahmad, and, T. P. Flanigan. 1996. Cryptosporidiosis: an unrecognized cause of diarrhea in elderly hospitalized patients. Clin. Infect. Dis. 22: 168– 170.
151.
Neu, H. C. 1967. Toxoplasmosis transmitted at autopsy. JAMA 202: 284– 285. (Letter.)
152.
Occupational Safety and Health Administration. 1991. Title 29 CFR Part 1910.1030. Protection from blood-borne pathogens. Fed. Regist. 56: 64175– 64182.
153.
Occupational Safety and Health Administration. 2001. Title 29 CFR Part 1910.1030. Occupational exposure to bloodborne pathogens: needlesticks and other sharp injuries; final rule. Fed. Regist. 66: 5317– 5325.
154.
Okhuysen, P. C.,, C. L. Chappell,, J. H. Crabb,, C. R. Sterling, and, H. L. DuPont. 1999. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J. Infect. Dis. 180: 1275– 1281.
155.
O’Mahony, C.,, A. Gardner, and, D. P. Casemore. 1992. Hospital-acquired cryptosporidiosis. P.H.L.S. Communicable Disease Report Review no. 2, p. R18–R19. Public Health Laboratory Service, London, United Kingdom.
156.
Parker, S. L., and, R. E. Holliman. 1992. Toxoplasmosis and laboratory workers: a case-control assessment of risk. Med. Lab. Sci. 49: 103– 106.
157.
Partanen, P.,, H. J. Turunen,, R. T. A. Paasivuo,, and P. O. Leinikki. 1984. Immunoblot analysis of Toxoplasma gondii antigens by human immunoglobulins G, M, and A antibodies at different stages of infection. J. Clin. Microbiol. 20: 133– 135.
158.
Pasticier, A.,, D. Méchali,, G. Saimot, J.-P. Coulaud, and, M. Payet. 1974. Paludisme autochtone: problèmes diagnostiques. Bull. Soc. Pathol. Exot. 67: 57– 64.
159.
Pavlásek, I. 1984. Effect of disinfectants in infectiousness of oocysts of Cryptosporidium sp. Cesk. Epidemiol. Microbiol. Imunol. 33: 97– 101. (With English summary.)
160.
Persing, D. H.,, B. L. Herwaldt,, C. Glaser,, R. S. Lane,, J. W. Thomford,, D. Mathiesen,, P. J. Krause,, D. F. Phillip, and, P. A. Conrad. 1995. Infection with a Babesia-like organism in northern California. N. Engl. J. Med. 332: 298– 303.
161.
Peters, S. E., and, R. A. Seaton. 2005. Bio-hazards and drug reactions: a cautionary tale. Scand. J. Infect. Dis. 37: 312– 313.
162.
Petithory, J., and, G. Lebeau. 1977. Contamination probable de laboratoire par Plasmodium falciparum. Bull. Soc. Pathol. Exot. 70: 371– 375.
163.
Pike, R. M. 1976. Laboratory-associated infections: summary and analysis of 3921 cases. Health Lab. Sci. 13: 105– 114.
164.
Pike, R. M. 1978. Past and present hazards of working with infectious agents. Arch. Pathol. Lab. Med. 102: 333– 336.
165.
Pike, R. M. 1979. Laboratory-associated infections: incidence, fatalities, causes, and prevention. Annu. Rev. Microbiol. 33: 41– 66.
166.
Pike, R. M.,, S. E. Sulkin, and, M. L. Schulze. 1965. Continuing importance of laboratory-acquired infections. Am. J. Public Health 55: 190– 199.
167.
Piro, S.,, M. Sammud,, S. Badi, and, L. Al Ssabi. 2001. Hospital-acquired malaria transmitted by contaminated gloves. J. Hosp. Infect. 47: 156– 158.
168.
Pizzi, T.,, G. Niedmann, and, A. Jarpa. 1963. Comunicación de tres casos de enfermedad de Chagas aguda producidos por infecciones accidentales de laboratorio. Bol. Chil. Parasitol. 18: 32– 36.
169.
Pohjola, S.,, H. Oksanen,, L. Jokipii, and, A. M. M. Jokipii. 1986. Outbreak of cryptosporidiosis among veterinary students. Scand. J. Infect. Dis. 18 :173– 178.
170.
Raffenot, D.,, O. Rogeaux,, B. De Goer, and, B. Zerr. 1999. Plasmodium falciparum malaria acquired by accidental inoculation. Eur. J. Clin. Microbiol. Infect. Dis. 18: 680– 681.
171.
Ravn, P.,, J. D. Lundgren,, P. Kjaeldgaard, W. Holten-Anderson,, N. Hojlyng, J. O. Nielsen, and, J. Gaub. 1991. Nosocomial outbreak of cryptosporidiosis in AIDS patients. Br. Med. J. 302: 277– 280.
172.
Rawal, B. D. 1959. Laboratory infection with Toxoplasma. J. Clin. Pathol. 12: 59– 61.
173.
Receveur, M. C., and, P. Vincendeau. 1993. Laboratory-acquired Gambian trypanosomiasis. N. Engl. J. Med. 329: 209– 210. (Letter.)
174.
Reif, J. S.,, L. Wimmer, J. A. Smith,, D. A. Dargatz, and, J. M. Cheney. 1989. Human cryptosporidiosis associated with an epizootic in calves. Am. J. Public Health 79: 1528– 1530.
175.
Remington, J. S., and, L. O. Gentry. 1970. Acquired toxoplasmosis: infection versus disease. Ann. N. Y. Acad. Sci. 174: 1006– 1017.
176.
Rendtorff, R. C. 1954. The experimental transmission of human intestinal protozoan parasites. II. Giardia lamblia cysts given in capsules. Am. J. Hyg. 59: 209– 220.
177.
Robertson, D. H. H.,, S. Pickens,, J. H. Lawson, and, B. Lennox. 1980. An accidental laboratory infection with African trypanosomes of a defined stock. I. The clinical course of the infection. J. Infect. 2: 105– 112.
178.
Roeckel, I. E., and, E. T. Lyons. 1977. Cutaneous larva migrans, an occupational disease. Ann. Clin. Lab. Sci. 7: 405– 410.
179.
Romi, R.,, D. Boccolini, and, G. Majori. 1999. Malaria surveillance in Italy: 1997 analysis and 1998 provisional data. Eurosurveillance Mont. 4: 85– 87.
180.
Roncoroni, A. J.,, M. A. Gomez,, J. Mera,, P. Cagnoni, and, M. D. Michel. 1989. Cryptosporidium infection in renal transplant patients. J. Infect. Dis 160: 559.
181.
Sabin, A. B.,, H. Eichenwald,, H. A. Feldman, and, L. Jacobs. 1952. Present status of clinical manifestations of toxoplasmosis in man: indications and provisions for routine serologic diagnosis. JAMA 150: 1063– 1069.
182.
Sadick, M. D.,, R. M. Locksley, and, H. V. Raff. 1984. Development of cellular immunity in cutaneous leishmaniasis due to Leishmania tropica. J. Infect. Dis. 150: 135– 138.
183.
Sampaio, R. N.,, L. M. P. de Lima,, A. Vexenat,, C. C. Cuba,, A. C. Barreto, and, P. D. Marsden. 1983. A laboratory infection with Leishmania braziliensis braziliensis. Trans. R. Soc. Trop. Med. Hyg. 77: 274. (Letter.)
184.
Sarabia-Arce, S.,, E. Salazar-Lindo,, R. H. Gilman,, J. Naranjo, and, E. Miranda. 1990. Case-control study of Cryptosporidium parvum infection in Peruvian children hospitalized for diarrhea: possible association with malnutrition and nosocomial infection. Pediatr. Infect. Dis.J. 9: 627– 631.
185.
Schmidt, L. H.,, R. Greenland, and, C. S. Genther. 1961. The transmission of Plasmodium cynomolgi to man. Am. J. Trop. Med. Hyg. 10: 679– 688.
186.
Schuman, S. H.,, A. T. Arnold, and, J. R. Rowe. 1982. Giardiasis by inhalation? Lancet i: 53.
187.
Sewell, D. L. 1995. Laboratory-associated infections and biosafety. Clin. Microbiol. Rev. 8: 389– 405.
188.
Sexton, R. C.,, D. E. Eyles, and, R. E. Dillman. 1953. Adult toxoplasmosis. Am. J. Med. 14: 366– 377. (Case reports.)
189.
Sprent, J. F. A. 1949. On the toxic and allergic manifestations produced by the tissues and fluids of Ascaris. I. Effect of different tissues. J. Infect. Dis. 84: 221– 229.
190.
Stone, O. J., and, A. Levy. 1967. Creeping eruption in an animal caretaker. Lab. Anim. Care 17: 479– 482.
191.
Strickland, G. T. (ed.). 2000. Hunter’s Tropical Medicine and Emerging Infectious Diseases, 8th ed. W. B. Saunders Co., Philadelphia, Pa.
192.
Ström, J. 1951. Toxoplasmosis due to laboratory infection in two adults. Acta Med. Scand. 139: 244– 252.
193.
Strout, R. G. 1962. A method for concentrating hemoflagellates. J. Parasitol. 48: 100.
194.
Sulkin, S. E., and, R. M. Pike. 1951. Survey of laboratory-acquired infections. Am. J. Public Health 41: 769– 781.
195.
Tarantola, A.,, A. Rachline,, C. Konto, S. Houzé,, C. Sabah-Mondan,, H. Vrillon,, E. Bouvet, and Group for the Prevention of Occupational Infections in Health Care Workers. 2005. Occupational Plasmodium falciparum malaria following accidental blood exposure: a case, published reports and considerations for post-exposure prophylaxis. Scand. J. Infect. Dis. 37: 131– 140.
196.
Tarantola, A. P.,, A. C. Rachline,, C. Konto,, S. Houzé,, S. Lariven,, A. Fichelle,, D. Ammar,, C. Sabah-Mondan,, H. Vrillon,, O. Bouchaud,, F. Pitard,, E. Bouvet, and Group for the Prevention of Occupational Infections in Health Care Workers. 2004. Occupational malaria following needlestick injury. Emerg. Infect. Dis. 10: 1878– 1880. (Letter.)
197.
Terry, L. L.,, J. L. Lewis, and, S. M. Sessoms. 1950. Laboratory infection with Leishmania donovani: a case report. Am. J. Trop. Med. 30: 643– 649.
198.
Teutsch, S. M.,, D. D. Juranek,, A. Sulzer, J. P. Dubey, and, R. K. Sikes. 1979. Epidemic toxoplasmosis associated with infected cats. N. Engl. J. Med. 300: 695– 699.
199.
Thalhammer, O. 1954. Zwei bemerkenswerte Fälle frischer Toxoplasmainfektion. Oesterr. Z. Kinderheilkd. 10: 316– 321.
200.
Turner, K. J.,, E. H. Fisher, and, A. S. McWilliam. 1980. Homology between roundworm and hookworm antigens detected by human IgE antibodies. Aust. J. Exp. Biol. Med. Sci. 58: 249– 257.
201.
Umdenstock, R.,, R. Mandoul, and, M. Pestre-Alexandre. 1965. Laboratory accident caused by the bite of a mouse infected with Toxoplasma. Autoobservation. Bull. Soc. Pathol. Exot. 58: 207– 209.
202.
Van Agtmael, M. A. 1997. A most unfortunate needlestick injury: why the doctor paid a taxi for the nurse. Br. Med. J. 314:( 1 February) [Online.] http://bmj.bmjjournals.com/cgi/content/full/314/7077/0/h?
203.
Van Gompel, A.,, E. Van den Enden,, J. Van den Ende, and, S. Geerts. 1993. Laboratory infection with Schistosoma mansoni. Trans. R. Soc. Trop. Med. Hyg 87: 554.
204.
Van Gool, T.,, C. Biderre,, F. Delbac,, E. WentinkBonnema,, R. Peek, and, C. P. Viavarès. 2004. Serodiagnostic studies in an immunocompetent individual infected with Encephalitozoon cuniculi. J. Infect. Dis. 189: 2243– 2249.
205.
Van Soestbergen, A. A. 1957. A laboratory infection with Toxoplasma gondii.Ned. Tijdschrift Geneeskd. 101: 1649– 1651.
206.
Varma, A. J. 1982. Malaria acquired by accidental inoculation. Can. Med. Assoc. J. 126: 1419– 1420.
207.
Western, K. A.,, M. G. Schultz,, W. E. Farrar, and, I. G. Kagan. 1969. Laboratory acquired Chagas’ disease treated with Bay [sic] 2502. Bol. Chil. Parasitol 24: 94.
208.
Wettingfeld, R. F.,, J. Rowe, and, D. E. Eyles. 1956. Treatment of toxoplasmosis with pyrimethamine (Daraprim) and triple sulfonamide. Ann. Intern. Med. 44: 557– 564. (Case reports.)
209.
Williams, J. L.,, B. T. Innis,, T. R. Burkot,, D. E. Hayes, and, I. Schneider. 1983. Falciparum malaria: accidental transmission to man by mosquitoes after infection with culture-derived gametocytes. Am. J. Trop. Med. Hyg. 32: 657– 659.
210.
Wilson, M.,, J. L. Jones,, and J. M. McAuley. 2003. Toxoplasma, p. 1970–1980. In P., R. Murray,, E. J. Baron,, M. A. Pfaller,, J. H. Jorgensen, and, R. H. Yolken (ed.), Manual of Clinical Microbiology, 8th ed. ASM Press, Washington, D.C.
211.
Wilson, M.,, P. M. Schantz,, and T. Nutman. 2006. Molecular and immunological approaches to the diagnosis of parasitic infections, p. 557–568. In B. Detrick,, R. G. Hamilton, and, J. D. Folds (ed.), Manual of Molecular and Clinical Laboratory Immunology, 7th ed. ASM Press, Washington, D.C.
212.
Winterberg, D. H.,, P. C. Wever,, C. van Rheenen-Verberg, O. Kempers, R. Durand, A. P. Bos, A. H. Teeuw, L. Spanjaard, and, J. Dankert. 2005. A boy with nosocomial malaria tropica contracted in a Dutch hospital. Pediatr. Infect. Dis. J. 24: 89– 91.
213.
Wittenberg, D. F.,, N. M. Miller, and, J. van den Ende. 1989. Spiramycin is not effective in treating Cryptosporidium diarrhea in infants: results of a double-blind randomized trial. J. Infect. Dis. 159: 131– 132.
214.
Woodison, G.,, A. H. Balfour, and, J. E. Smith. 1993. Sequential reactivity of serum against cyst antigens in Toxoplasma infection. J. Clin. Pathol. 46: 548– 550.
215.
Wright, W. H. 1957. A summary of the newer knowledge of toxoplasmosis. Am. J. Clin. Pathol. 28: 1– 17.
216.
Zeledón, R. 1974. Epidemiology, modes of transmission and reservoir hosts of Chagas’ disease, p. 51–85. In Ciba Foundation Symposium 20 (new series), Trypanosomiasis and Leishmaniasis with Special Reference to Chagas’ Disease. Associated Scientific Publishers, Amsterdam, The Netherlands.
217.
Zimmermann, W. J. 1976. Prevalence of Toxoplasma gondii antibodies among veterinary college staff and students, Iowa State University. Public Health Rep. 91: 526– 532.
Tables
Protozoa and Helminths
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815899.ch07-1,webId=/content/author/10.1128/9781555815899.ch07-1,properties={foaf_givenname=Barbara L., foaf_name=Barbara L. Herwaldt, foaf_surname=Herwaldt}]]
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab01
TABLE 1
Natural pathogens of common laboratory animals
a
TABLE 1
Natural pathogens of common laboratory animals a
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab02
TABLE 2
Factors that affect whether accidental exposures to parasites cause infection and disease
TABLE 2
Factors that affect whether accidental exposures to parasites cause infection and disease
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab03
TABLE 3
Available data about rates of laboratory accidents and infections with specific parasites
a
TABLE 3
Available data about rates of laboratory accidents and infections with specific parasites a
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab04
TABLE 4
Criteria for including occupationally acquired (“laboratory-acquired”) cases of parasitic infection in this chapter and examples of types of cases that were and were not included
a
TABLE 4
Criteria for including occupationally acquired (“laboratory-acquired”) cases of parasitic infection in this chapter and examples of types of cases that were and were not included a
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab05
TABLE 5
Number of reported cases of occupationally acquired parasitic infections
TABLE 5
Number of reported cases of occupationally acquired parasitic infections
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab06
TABLE 6
Antibody and antigen detection tests available
a
in the United States for parasitic diseases
b
TABLE 6
Antibody and antigen detection tests available a in the United States for parasitic diseases b
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab07
TABLE 7
Examples of practices and occurrences that have resulted in laboratory-acquired parasitic infections
TABLE 7
Examples of practices and occurrences that have resulted in laboratory-acquired parasitic infections
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab08
TABLE 8
Number of reported cases of laboratory-acquired infections caused by blood and tissue protozoa, by decade of occurrence (if known) or publication
a
TABLE 8
Number of reported cases of laboratory-acquired infections caused by blood and tissue protozoa, by decade of occurrence (if known) or publication a
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab09
TABLE 9
Number of reported cases of laboratory-acquired infections caused by blood and tissue protozoa, by country or region of the world where the case occurred
a
TABLE 9
Number of reported cases of laboratory-acquired infections caused by blood and tissue protozoa, by country or region of the world where the case occurred a
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab10
TABLE 10
Number of reported cases of laboratory-acquired infections caused by blood and tissue protozoa, by known or likely route of exposure
a
TABLE 10
Number of reported cases of laboratory-acquired infections caused by blood and tissue protozoa, by known or likely route of exposure a
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab11
TABLE 11
Characteristics of the reported cases of laboratory-acquired infection with Leishmania spp.
a
TABLE 11
Characteristics of the reported cases of laboratory-acquired infection with Leishmania spp. a
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab12
TABLE 12
Characteristics of the reported cases of laboratory-acquired infection with Plasmodium spp.
a
TABLE 12
Characteristics of the reported cases of laboratory-acquired infection with Plasmodium spp. a
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab13
TABLE 13
Characteristics of the reported cases of laboratory-acquired infection with T. gondii
a
TABLE 13
Characteristics of the reported cases of laboratory-acquired infection with T. gondii a
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab14
TABLE 14
Characteristics of the reported cases of laboratory-acquired infection with T. cruzi
a
TABLE 14
Characteristics of the reported cases of laboratory-acquired infection with T. cruzi a
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab15
TABLE 15
Clinical and laboratory monitoring for T. cruzi infection after accidental exposures
TABLE 15
Clinical and laboratory monitoring for T. cruzi infection after accidental exposures
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab16
TABLE 16
Practical guide for detection of circulating T. cruzi trypomastigotes by light microsopy
a
TABLE 16
Practical guide for detection of circulating T. cruzi trypomastigotes by light microsopy a
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7
/content/10.1128/9781555815899.ch07.ch07tab17
TABLE 17
Characteristics of the reported cases of laboratory-acquired infection with T. brucei subspp.
a
TABLE 17
Characteristics of the reported cases of laboratory-acquired infection with T. brucei subspp. a
Citation:
Herwaldt B.
2006.
Protozoa and Helminths,
p 115-161.
In
Fleming D, Hunt D (ed),
Biological Safety.
ASM Press, Washington, DC.
doi: 10.1128/9781555815899.ch7